IRCT20200105046010N20招募中未知
Pharmacokinetic assessments of of Sitagliptine/ Metformin 50/500 tablet (??Dicemia) Kooshan Pharmed Co with brand drugs (JANUMET 50/500mg (Merck Sharp & Dohme, Gremany) in Iranian healthy volunteers
Koushan Pharmed Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health (liver, heart, kidney)
- •Body Mass Index (BMI) between 18-28
- •Informed consent
- •Age between 18-60
- •Both male and female
排除标准
- •Hypersensitivity to the drug
- •Alcohol & Drug addiction
研究者
相似试验
尚未招募
不适用
Study of Sitagliptine/ Metformin table In-Vivo Bioequivalence in healthy volunteersIn this study the bioequivalence of test and brand of Linagliptin tablets 5mg will evaluated..IRCT20200105046010N12Razak Pharma24
已完成
不适用
Efficacy and Safety comparison of Sitagliptin and Glimepiride in elderly Japanese patients with type 2 diabetestype 2 diabetesJPRN-UMIN000004047Japan Association for Diabetes Education and Care900
招募中
2 期
?Evaluation the effects of Sitagliptin administration in patients with COVID-19Pneumonia of COVID-19.COVID-19, virus identifiedU07.1IRCT20200420047147N1Shahid Beheshti University of Medical Sciences84
已完成
2 期
Sitagliptin and Pioglitazon effects in the treatment of diabetesIRCT2015061619554N4Vice chancellor for research; Zanjan University of Medical Sciences160
尚未招募
4 期
A clinical study to understand the combined effects ofSitagliptin & metformin, in comparison to Glimepiride & metformin treatment in type 2 diabetes patientsCTRI/2024/04/065877Dr Keerthi Rajan M